08 Sep 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
08 Sep 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
01 Sep 2025
18:00 CEST |
OXURION |
Oxurion confirme l'avancée des négociations relatives à sa stratégie de diversification de sa trésorerie ; un closing de l'opération est envisagé avant le 25 septembre 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van UBS Group AG
|
20103010 Biotechnology |
Change in Capital |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from UBS Group AG
|
20103010 Biotechnology |
Change in Capital |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion Ends RD Program in Geographic Atrophy and Refocuses on New CRO Activities
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
07 Aug 2025
18:00 CEST |
OXURION |
Oxurion met fin à son programme de RD sur la dégénérescence maculaire géographique et se recentre sur ses nouvelles activités de CRO
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
06 Aug 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
06 Aug 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
04 Aug 2025
18:00 CEST |
OXURION |
Oxurion obtient une offre de financement revue à la hausse à 30 M EUR pour lancer la diversification de sa trésorerie en actifs numériques
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
04 Aug 2025
18:00 CEST |
OXURION |
Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
04 Aug 2025
08:30 CEST |
OXURION |
Oxurion finalise l'acquisition d'Axiodis CRO et accélère la structuration de son pôle européen dédié à la donnée clinique
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
04 Aug 2025
08:30 CEST |
OXURION |
Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
30 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
30 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
25 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
25 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
24 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
24 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
23 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
23 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
23 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
23 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
22 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
22 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
22 Jul 2025
08:30 CEST |
OXURION |
Oxurion plans to launch a treasury diversification strategy into digital assets under a EUR 10M indicative agreement with its main investor
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
22 Jul 2025
08:30 CEST |
OXURION |
Oxurion envisage de lancer une stratégie de diversification de sa trésorerie en actifs numériques dans le cadre d'un accord indicatif de 10 M EUR avec son principal investisseur
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
09:05 CEST |
OXURION |
Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
09:00 CEST |
OXURION |
Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1eraoût 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
08:30 CEST |
OXURION |
Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1er août 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
17 Jul 2025
08:30 CEST |
OXURION |
Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
15 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
15 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
14 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
14 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
10 Jul 2025
17:45 CEST |
OXURION |
Oxurion Announces the Fulfilment of the Second Condition Precedent in the Acquisition of Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
10 Jul 2025
17:45 CEST |
OXURION |
Oxurion annonce la levée de la seconde condition suspensive dans l'acquisition d'Axiodis
|
20103010 Biotechnology |
Alliances and agreements, Mergers, Acquisitions, Transfers |
04 Jul 2025
18:00 CEST |
OXURION |
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
|
20103010 Biotechnology |
Change in Capital |
04 Jul 2025
18:00 CEST |
OXURION |
Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
|
20103010 Biotechnology |
Change in Capital |
03 Jul 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
03 Jul 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
30 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
25 Jun 2025
18:00 CEST |
OXURION |
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |
25 Jun 2025
18:00 CEST |
OXURION |
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
|
20103010 Biotechnology |
Change in Capital |